India: new strategy to boost pharma exports

http://newdrugapprovals.wordpress.com/2013/05/29/india-new-strategy-to-boost-pharma-exports/

European Commission Approves Stribild, a New Single Tablet Regimen for the Treatment of HIV-1 Infection

http://newdrugapprovals.wordpress.com/2013/05/29/european-commission-approves-stribild-a-new-single-tablet-regimen-for-the-treatment-of-hiv-1-infection/

AstraZeneca to Acquire Omthera Pharmaceuticals in $443M Deal

http://newdrugapprovals.wordpress.com/2013/05/29/astrazeneca-to-acquire-omthera-pharmaceuticals-in-443m-deal/

Top Japanese Pharmaceutical Companies and Their Pipelines 2011

http://newdrugapprovals.wordpress.com/2013/05/29/top-japanese-pharmaceutical-companies-and-their-pipelines-2011/

Celgene sNDA of Abraxane obtains FDA priority review status

http://drugdelivery.pharmaceutical-business-review.com/news/celgene-snda-of-abraxane-obtains-fda-priority-review-status-240513

Sonepcizumab/LT1009-US-based Lpath has begun patient dosing in Phase 2a single-arm trial of anti-cancer drug, Asonep.

http://newdrugapprovals.wordpress.com/2013/05/28/sonepcizumablt1009-us-based-lpath-has-begun-patient-dosing-in-phase-2a-single-arm-trial-of-anti-cancer-drug-asonep/

Swedish pharmaceutical company Moberg Pharma has completed enrolling patients in the ongoing Phase II trial of MOB-015 for the treatment of nail fungus (onychomycosis).

http://newdrugapprovals.wordpress.com/2013/05/28/swedish-pharmaceutical-company-moberg-pharma-has-completed-enrolling-patients-in-the-ongoing-phase-ii-trial-of-mob-015-for-the-treatment-of-nail-fungus-onychomycosis/